FDAsafety guidance66% confidence
FDA TA — ANDA220086
Source: FDA
Why This Matters
Why this matters: provides agency context on safety guidance that may shape timing or evidence expectations for Sandoz; the same agency is already in play for this signal, so precedent weight is higher.
Regulatory Analysis
Application ANDA220086. Sponsor: SANDOZ INC. Submission status: TA. Submission type: ORIG. Review priority: STANDARD.
Supporting Context
- Therapeutic area
- Not specified
- Sub-indication
- General
Related signal: Sandoz Inc. Submits ANDA220086 for FDA Review